- Home
- Research
- Funded Research
- Fellowship Program
- Research News
- Screening for PAH in Systemic Sclerosis: Does It Matter?
- Stimulation of soluble guanylate cyclase reduces experimental dermal fibrosis
- Emerging patterns of genetic overlap across autoimmune disorders.
- An Evaluation of Long-Term Survival From Time of Diagnosis in Pulmonary Arterial Hypertension From REVEAL.
- Evidence of the contribution of the X chromosome to systemic sclerosis susceptibility: association with the functional IRAK1 196Phe/532Ser haplotype.
- Elevated expression of cav-1 in a subset of SSc fibroblasts contributes to constitutive Alk1/Smad1 activation.
- Work productivity in scleroderma: Analysis from the University of California, Los Angeles scleroderma quality of life study
- Mechanism, Potential Therapy for Scleroderma Lung Disease Uncovered
- Serum COMP-C3b complexes in rheumatic diseases and relation to anti-TNF-alpha treatment
- Left ventricular dysfunction assessed by speckle-tracking strain analysis in patients with systemic sclerosis: relationship to functional capacity and ventricular arrhythmias.
- Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers
- NEFA/nucleobindin-2 is a target autoantigen of the anti-Wa antibody and is associated with transfer RNA.
- Haemopoietic stem-cell transplantation for systemic sclerosis
- Emerging targeted therapies in scleroderma lung and skin fibrosis.
- Anti-PM-Scl antibody in patients with systemic sclerosis.
- Response to self antigen imprints regulatory memory in tissues
- Agreement with Guidelines from a Large Database for Management of Systemic Sclerosis: Results from the Canadian Scleroderma Research Group.
- Warfarin in Systemic Sclerosis-associated and Idiopathic Pulmonary Arterial Hypertension. A Bayesian Approach to Evaluating Treatment for Uncommon Disease.
- Methotrexate and Corticosteroids in the Treatment of Localized Scleroderma: A Standardized Prospective Longitudinal Single-center Study
- Gender and ethnicity differences in the prevalence of scleroderma-related autoantibodies.
- Demographic, clinical and antibody characteristics of patients with digital ulcers in systemic sclerosis: data from the DUO Registry.
- Thoracic manifestations of collagen vascular diseases.
- SSc in 2011: From mechanisms to medicines
- Analysis of extracellular superoxide dismutase in fibroblasts from patients with systemic sclerosis.
- Unraveling the genetic component of systemic sclerosis.
- An Update on the Evaluation and Management of Pulmonary Hypertension in Scleroderma.
- Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities
- The impact of cardio-pulmonary manifestations on the mortality of SSc: a systematic review and meta-analysis of observational studies.
- Cytokine modulation by endothelin-1 and possible therapeutic implications in systemic sclerosis.
- Circulating fibrocytes and pulmonary arterial hypertension
- Polymorphisms in the Interleukin 4, Interleukin 13, and Corresponding Receptor Genes Are Not Associated with Systemic Sclerosis and Do Not Influence Gene Expression
- Association Between Thr21Met and Ser89Asn Polymorphisms of the Urotensin II Gene and Systemic Sclerosis
- Localized expression of tenascin in systemic sclerosis–associated pulmonary fibrosis and its regulation by insulin-like growth factor binding protein 3
- Analysis of extracellular superoxide dismutase in fibroblasts from patients with systemic sclerosis.
- Combination Therapy in Pulmonary Arterial Hypertension: A Meta-Analysis.
- Dendritic Cells: Novel Players in Fibrosis and Scleroderma
- Scientific Advisory Board
- Bruce Alberts, PhD (Chair)
- David Botstein, PhD
- Shaun R. Coughlin, MD, PhD
- Dan Kastner, MD, PhD
- Regis B. Kelly, PhD
- Henry Metzger, MD
- Antony Rosen, MD
- William J. Rutter, PhD
- Bruce U. Wintroub, MD
- George Yancopoulos, MD, PhD
- Closing Text
- Grant Guidelines and Applications
- About Us
- History
- Board of Directors
- Scientific Advisory Board
- Bruce Alberts, PhD (Chair)
- David Botstein, PhD
- Shaun R. Coughlin, MD, PhD
- Dan Kastner, MD, PhD
- Regis B. Kelly, PhD
- Henry Metzger, MD
- Antony Rosen, MD
- William J. Rutter, PhD
- Bruce U. Wintroub, MD
- George Yancopoulos, MD, PhD
- Closing Text
- Annual Report
- SRF in the News
- Downloads
- Get Involved
- Cure Crew
- For Patients
- News for Patients
- Screening for PAH in Systemic Sclerosis: Does It Matter?
- Emerging patterns of genetic overlap across autoimmune disorders.
- An Evaluation of Long-Term Survival From Time of Diagnosis in Pulmonary Arterial Hypertension From REVEAL.
- Evidence of the contribution of the X chromosome to systemic sclerosis susceptibility: association with the functional IRAK1 196Phe/532Ser haplotype.
- Mechanism, Potential Therapy for Scleroderma Lung Disease Uncovered
- Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers
- Work productivity in scleroderma: Analysis from the University of California, Los Angeles scleroderma quality of life study
- Haemopoietic stem-cell transplantation for systemic sclerosis
- Emerging targeted therapies in scleroderma lung and skin fibrosis.
- 32 Million Americans Have Autoantibodies That Target Their Own Tissues
- Methotrexate and Corticosteroids in the Treatment of Localized Scleroderma: A Standardized Prospective Longitudinal Single-center Study
- New NIH center translates research into real-world use
- SSc in 2011: From mechanisms to medicines
- Pulmonary hypertension in kids differs from adult PAH
- Top 10 Medical Research Trends to Watch in 2012
- Unraveling the genetic component of systemic sclerosis.
- Preterm Delivery a Risk in Systemic Sclerosis
- An Update on the Evaluation and Management of Pulmonary Hypertension in Scleroderma.
- Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities
- The impact of cardio-pulmonary manifestations on the mortality of SSc: a systematic review and meta-analysis of observational studies.
- Commonly Used Blood Pressure Drug Prevents Smoking-Related Lung Damage in Mice
- New Uses for Existing Medicines
- Pulmonary complications of childhood rheumatic disease.
- Successful pregnancies but a higher risk of preterm births in systemic sclerosis: An Italian multicentric study
- Environmental triggers and epigenetic deregulation in autoimmune disease.
- Scleroderma Mimics
- Gastrointestinal Manifestations of Scleroderma: Recent Progress in Evaluation, Pathogenesis, and Management
- NIH establishes National Center for Advancing Translational Sciences
- Genetics of Systemic Sclerosis: An Update
- Sex differences and genomics in autoimmune diseases.
- Winter Weather Skin Conditions: The Trifecta
- International Journal of Rheumatology - Systemic Sclerosis Annual Special Issue
- A decade of achievement in pulmonary hypertension
- American College of Rheumatology - Simple Tasks Video Series
- How To Look And Feel Beautiful With Autoimmune Disease
- Application of Biomarkers to Clinical Trials in Systemic Sclerosis.
- Formula Calculates Need for Heart Catheterization in SSc
- What is scleroderma
- Frequently Asked Questions
- Risk Factors
- Tips for Living
- Clinical Trials
- Current Treatments
- Treatment Centers
- Additional Resources
- Webinars
- For Physicians
- Contact Us
- Donate
|
|
 |
|
Sitemap
